STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines

Abstract Background Obstructive sleep apnea (OSA) is frequently associated with increased incidence and mortality of pulmonary hypertension (PH). The immune response contributes to pulmonary artery remodeling and OSA-related diseases. The immunologic factors linked to OSA-induced PH are not well und...

Full description

Saved in:
Bibliographic Details
Main Authors: Pan Jiang, Huai Huang, Zilong Liu, Guiling Xiang, Xiaodan Wu, Shengyu Hao, Shanqun Li
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-024-03062-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594497542815744
author Pan Jiang
Huai Huang
Zilong Liu
Guiling Xiang
Xiaodan Wu
Shengyu Hao
Shanqun Li
author_facet Pan Jiang
Huai Huang
Zilong Liu
Guiling Xiang
Xiaodan Wu
Shengyu Hao
Shanqun Li
author_sort Pan Jiang
collection DOAJ
description Abstract Background Obstructive sleep apnea (OSA) is frequently associated with increased incidence and mortality of pulmonary hypertension (PH). The immune response contributes to pulmonary artery remodeling and OSA-related diseases. The immunologic factors linked to OSA-induced PH are not well understood. STAT6 is crucial in the signaling pathway that modulates immune response. However, the status of phosphorylated STAT6 (p-STAT6) in an OSA-induced PH mouse model remains largely unexplored. Methods Chronic intermittent hypoxia (CIH) plays a crucial role in the progression of OSA. This study utilized a in vivo CIH model to examine the role of STAT6 in CIH-induced PH. Results CIH mice exhibited pulmonary artery remodeling and pulmonary hypertension, indicated by increased right ventricular systolic pressure (RVSP), higher right ventricular to left ventricular plus septum (RV/LV + S) ratios, and significant morphological alterations compared to normoxic (Nor) mice. Increased p-STAT6 in the lungs and elevated p-STAT6 + IL-4 + producing T cells in CIH mice. STAT6 deficiency (STAT6-/-) improved PH and PA remodeling in CIH-induced PH mouse models.STAT6 deficiency impaired the T helper 2 (Th2) immune response, affecting IL-4 and IL-13 secretion. IL-4, rather than IL-13, activated STAT6 in human pulmonary artery smooth muscle cells (hPASMCs). STAT6 knockdown decreased the proliferation in IL-4 treated hPASMCs. Conclusion These findings exhibit the critical role of STAT6 in the pathogenesis of CIH induced PH by regulating Th2 immune response.STAT6 could be a significant therapeutic target for OSA-related PH.
format Article
id doaj-art-9df0128f9dda4297b8f0483779b71e44
institution Kabale University
issn 1465-993X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj-art-9df0128f9dda4297b8f0483779b71e442025-01-19T12:36:29ZengBMCRespiratory Research1465-993X2025-01-0126111410.1186/s12931-024-03062-zSTAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokinesPan Jiang0Huai Huang1Zilong Liu2Guiling Xiang3Xiaodan Wu4Shengyu Hao5Shanqun Li6Department of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan UniversityAbstract Background Obstructive sleep apnea (OSA) is frequently associated with increased incidence and mortality of pulmonary hypertension (PH). The immune response contributes to pulmonary artery remodeling and OSA-related diseases. The immunologic factors linked to OSA-induced PH are not well understood. STAT6 is crucial in the signaling pathway that modulates immune response. However, the status of phosphorylated STAT6 (p-STAT6) in an OSA-induced PH mouse model remains largely unexplored. Methods Chronic intermittent hypoxia (CIH) plays a crucial role in the progression of OSA. This study utilized a in vivo CIH model to examine the role of STAT6 in CIH-induced PH. Results CIH mice exhibited pulmonary artery remodeling and pulmonary hypertension, indicated by increased right ventricular systolic pressure (RVSP), higher right ventricular to left ventricular plus septum (RV/LV + S) ratios, and significant morphological alterations compared to normoxic (Nor) mice. Increased p-STAT6 in the lungs and elevated p-STAT6 + IL-4 + producing T cells in CIH mice. STAT6 deficiency (STAT6-/-) improved PH and PA remodeling in CIH-induced PH mouse models.STAT6 deficiency impaired the T helper 2 (Th2) immune response, affecting IL-4 and IL-13 secretion. IL-4, rather than IL-13, activated STAT6 in human pulmonary artery smooth muscle cells (hPASMCs). STAT6 knockdown decreased the proliferation in IL-4 treated hPASMCs. Conclusion These findings exhibit the critical role of STAT6 in the pathogenesis of CIH induced PH by regulating Th2 immune response.STAT6 could be a significant therapeutic target for OSA-related PH.https://doi.org/10.1186/s12931-024-03062-zChronic intermittent hypoxiaPulmonary hypertensionSTAT6Th2 immune response
spellingShingle Pan Jiang
Huai Huang
Zilong Liu
Guiling Xiang
Xiaodan Wu
Shengyu Hao
Shanqun Li
STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
Respiratory Research
Chronic intermittent hypoxia
Pulmonary hypertension
STAT6
Th2 immune response
title STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
title_full STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
title_fullStr STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
title_full_unstemmed STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
title_short STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines
title_sort stat6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing th2 inducing cytokines
topic Chronic intermittent hypoxia
Pulmonary hypertension
STAT6
Th2 immune response
url https://doi.org/10.1186/s12931-024-03062-z
work_keys_str_mv AT panjiang stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT huaihuang stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT zilongliu stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT guilingxiang stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT xiaodanwu stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT shengyuhao stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines
AT shanqunli stat6deficiencymitigatestheseverityofpulmonaryarterialhypertensioncausedbychronicintermittenthypoxiabysuppressingth2inducingcytokines